SCYNEXIS to Participate in Upcoming Investor Conferences

Nov 28, 2017

SCYNEXIS to Present at the 29th Annual Piper Jaffray Healthcare Conference

Nov 22, 2017

SCYNEXIS Appoints Scott Sukenick as General Counsel

Nov 16, 2017

SCYNEXIS Reports Third Quarter 2017 Financial Results and Provides Company Update

Nov 7, 2017

SCYNEXIS Presents New Data Further Supporting SCY-078 as a Potential Treatment for Aspergillus and Candida Infections at IDWeek 2017

Oct 5, 2017

SCYNEXIS to Present Data on Lead Antifungal Candidate SCY-078 at IDWeek 2017

Sep 27, 2017

SCYNEXIS to Present at Upcoming Investor Conferences

Aug 31, 2017

“THINK FUNGUS” - SCYNEXIS Recognizes Fungal Disease Awareness Week Sponsored by the Centers for Disease Control and Prevention (CDC)

Aug 15, 2017

SCYNEXIS Presents New Data Supporting Oral SCY-078 for the Clinical Treatment of Vulvovaginal Candidiasis Infections at the 2017 IDSOG Annual Meeting

Aug 14, 2017

SCYNEXIS Reports Second Quarter 2017 Financial Results and Provides Company Update

Aug 8, 2017